Welireg 40 mg, Filmtabletten - 90 Swissmedic Key 68531001 Registration Holder MSD Merck Sharp & Dohme AG Name Welireg 40 mg, Filmtabletten Date of registration 21.03.2024 Introduction of Sequence 21.03.2024 ATC-Classification Revision date WHO Valid until 21.03.2026 Index Therapeuticus (BSV) Show package size 90 Index Therapeuticus (Swissmedic) 07.16.40. Description Swissmedic categorie. A SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680685310019 Medication Code Synthetika Pharmacode Disponibility
Composition belzutifanum 40 mg, hypromellosi acetas succinas, cellulosum microcristallinum, mannitolum, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 132, pro compresso obducto corresp. natrium 1.356 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Belzutifanum 40 mg
Inactive agents Dose additional_information Carmellosum Natricum Conexum Cellulosum Microcristallinum E 132 color. E 171 color. Hypromellosi Acetas Succinas Macrogol 3350 Magnesii Stearas Mannitol Poly(Alcohol Vinylicus) Überzug Pro Compresso Obducto Silica Colloidalis Anhydrica Talcum
Source Data was imported : 04.04.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
